| S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial 2020 · TAS-118 plus oxaliplatin · Adults aged 20 years or older with untreated advanced gastric cancer | 50 mg | — | 356 |
| Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial 2016 · UFT/LV group · Adults aged 20–80 years with colorectal cancer liver metastases after curative hepatic resection | 75 mg | 25 weeks | 90 |
| A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer 2016 · S-1/LV (SL group) · Adults aged 20–79 with gemcitabine-refractory advanced pancreatic cancer | 50 mg | — | 69 |
| Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorin 2003 · group A · Patients with metastatic colorectal cancer | 30 mg | — | 38 |
| Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens 1997 · Oral 5-dFUR group · Adults with metastatic or locally advanced colorectal cancer resistant to 5-fluorouracil | 25 mg | — | 34 |
| L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials 2012 · Trial 1: placebo for 30 days followed by L-methylfolate · Outpatients with SSRI-resistant major depressive disorder and a partial or no response to SSRIs | 7.5 mg | 30 days | — |
| L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials 2012 · Trial 2: L-methylfolate for 60 days · Outpatients with SSRI-resistant major depressive disorder and a partial or no response to SSRIs | 15 mg | 60 days | — |
| Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer 2002 · UFT and LV · Previously untreated patients with metastatic colorectal cancer | 90 mg | — | — |
| Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial 2012 · standard multivitamin with high doses of folic acid, vitamin B6 and vitamin B12 · Men and women aged 35–75 years, at least 6 months after kidney transplant, with stable kidney function and elevated serum homocysteine | 1 mg | — | — |
| Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial 2012 · multivitamin containing low doses of vitamin B6 and vitamin B12 with no folic acid · Men and women aged 35–75 years, at least 6 months after kidney transplant, with stable kidney function and elevated serum homocysteine | 2 mcg | — | — |
| Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status 2010 · LV group · Children aged 3–30 months with complete, homogeneous trisomy 21 (Down syndrome) | 1 mg/kg | 1 year | 56 |
| Safety and Efficacy of High-Dose Folinic Acid in Children with Autism: The Impact of Folate Metabolism Gene Polymorphisms 2025 · intervention group · Children aged 3–6 years with autism spectrum disorder | 2 mg/kg | 12 weeks | 50 |
| Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study 1993 · 5'-MTHF · Elderly normofolatemic patients with mild to moderate dementia and depression | 50 mg | 8 weeks | 47 |
| Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial 2024 · folinic acid group · Children aged 2–10 years with autism spectrum disorder | 2 mg/kg | 24 weeks | 40 |
| Long-Chain Polyunsaturated Fatty Acids, Homocysteine at Birth and Fatty Acid Desaturase Gene Cluster Polymorphisms are Associated with Children's Processing Speed up to Age 9 Years 2020 · 5-MTHF · Healthy pregnant women; offspring were assessed at 7.5 and 9 years | 400 mcg | — | 29 |
| Short-term folinic acid supplementation improves vascular reactivity in HIV-infected individuals: a randomized trial 2013 · folinic acid · HIV-infected adults receiving antiretroviral therapy, with undetectable viral load and CD4 cell count above 200 cells/mm³ | 5 mg | 4 weeks | 15 |
| Short-term folinic acid supplementation and aerobic exercise improve vascular reactivity in HIV-infected individuals 2018 · folinic acid group · HIV-infected individuals receiving antiretroviral therapy for at least 6 months and with undetectable viral load | 5 mg | 4 weeks | 6 |
| Enhancement of recovery from psychiatric illness by methylfolate 1990 · methylfolate · Patients with acute major depression or schizophrenia and borderline or definite folate deficiency | 15 mg | 26 weeks | — |
| Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age 2011 · 5-MTHF group · healthy pregnant women | 400 mcg | — | — |
| Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial 2014 · L-methylfolate for 60 days · Outpatients with SSRI-resistant major depressive disorder | 15 mg | 60 days | — |
| Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial 2014 · Placebo for 30 days followed by L-methylfolate for 30 days · Outpatients with SSRI-resistant major depressive disorder | 15 mg | 30 days | — |
| Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial 2020 · folinic acid group · children with autism spectrum disorder | 10 mg | 12 weeks | — |
| Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial 2021 · folinic acid group · Children with autism spectrum disorder; mean age 13.40 years; 35 male and 20 female across the trial | 2 mg/kg | 10 weeks | — |
| Long-Chain Polyunsaturated Fatty Acids, Homocysteine at Birth and Fatty Acid Desaturase Gene Cluster Polymorphisms are Associated with Children's Processing Speed up to Age 9 Years 2020 · FO + 5-MTHF · Healthy pregnant women; offspring were assessed at 7.5 and 9 years | 400 mcg | — | 36 |
| An encapsulated juice powder concentrate improves markers of pulmonary function and cardiovascular risk factors in heavy smokers 2013 · FV group · Apparently healthy men and women aged 46.6 ± 7.9 years, current heavy smokers without respiratory complications | 420 mcg | 90 days | 26 |
| An encapsulated juice powder concentrate improves markers of pulmonary function and cardiovascular risk factors in heavy smokers 2013 · FVB group · Apparently healthy men and women aged 49.9 ± 11.4 years, current heavy smokers without respiratory complications | 600 mcg | 90 days | 24 |
| Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age 2011 · combined fish-oil and 5-MTHF group · healthy pregnant women | 400 mcg | — | — |
| B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial 2014 · B vitamins only · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke | 560 mcg | 1716 days | — |
| Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study 2022 · Mg-Teadiola · Adults aged 18–65, either sex, otherwise healthy and chronically stressed (DASS-42 stress score ≥14) | 100 mcg | 4 weeks | 51 |
| Association of serum homocysteine, folate, and vitamin B(12) and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: Secondary analysis of the WAVES trial 2023 · Swank diet group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; ages and sex not specified | 1 g | 24 weeks | 37 |
| Association of serum homocysteine, folate, and vitamin B(12) and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: Secondary analysis of the WAVES trial 2023 · Wahls diet group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; ages and sex not specified | 1 g | 24 weeks | 35 |
| B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial 2014 · B vitamins plus n-3 fatty acids · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke | 560 mcg | 1716 days | — |
| Efficacy of L-methylfolate and methylcobalamin in treating resistant hypertension associated with elevated serum homocysteine in hemodialysis patients 2026 · treatment group · Adults with end-stage renal disease undergoing maintenance hemodialysis, resistant hypertension, and elevated homocysteine; ages 25–73 in the analyzed treatment group | 800 mcg | 90 days | 25 |
| The effectiveness of daily supplementation with 400 or 800 µg/day folate in reaching protective red blood folate concentrations in non-pregnant women: a randomized trial 2018 · 800 µg/day group · Healthy non-pregnant women aged 18–45 years | 800 mcg | 8 weeks | 101 |
| The effectiveness of daily supplementation with 400 or 800 µg/day folate in reaching protective red blood folate concentrations in non-pregnant women: a randomized trial 2018 · 400 µg/day group · Healthy non-pregnant women aged 18–45 years | 400 mcg | 8 weeks | 100 |
| Response of Red Blood Cell Folate to Supplementation in Nonpregnant Women is Predictable: A Proposal for Personalized Supplementation 2018 · 400 μg/day folate group · Healthy nonpregnant women aged 18–45 with baseline RBC-folate below 906 nmol/L | 400 mcg | 8 weeks | 88 |
| Response of Red Blood Cell Folate to Supplementation in Nonpregnant Women is Predictable: A Proposal for Personalized Supplementation 2018 · 800 μg/day folate group · Healthy nonpregnant women aged 18–45 with baseline RBC-folate below 906 nmol/L | 800 mcg | 8 weeks | 84 |
| Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial 2018 · L-methylfolate · Adults with schizophrenia receiving medication; age and sex distribution are not specified in the text. | 15 mg | 12 weeks | 29 |
| [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase 2009 · [6S]-5-MTHF · healthy females with either the homozygous (TT) or wild-type (CC) MTHFR 677C→T genotype | 416 mcg | 1 day | 24 |
| Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts 2020 · (6S)-5-Methyl-THF-Na · Healthy men and women aged 18–50 years | 436 mcg | 1 day | 24 |
| Determining bioavailability of food folates in a controlled intervention study 2004 · yeast folate group · men; age and health status not specified | 200 mcg | 30 days | 19 |
| Determining bioavailability of food folates in a controlled intervention study 2004 · spinach folate group · men; age and health status not specified | 200 mcg | 30 days | 18 |
| Aleurone flour is a rich source of bioavailable folate in humans 1999 · 100 g aleurone cereal · Men and women aged 29–50 years; no condition stated | 100 g | 1 day | 16 |
| The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation 2006 · egg yolk folate · 13 male subjects after a prestudy folate saturation procedure | 500 mcg | 1 day | 13 |
| The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation 2006 · spinach folate · 13 male subjects after a prestudy folate saturation procedure | 500 mcg | 1 day | 13 |
| The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation 2006 · yeast folate · 13 male subjects after a prestudy folate saturation procedure | 500 mcg | 1 day | 13 |
| Molecular determinants of folate levels after leucovorin administration in colorectal cancer 2010 · LV 4 h group · Colorectal cancer patients scheduled to undergo surgery | 25 mg | 1 day | 10 |
| Molecular determinants of folate levels after leucovorin administration in colorectal cancer 2010 · LV 12 h group · Colorectal cancer patients scheduled to undergo surgery | 25 mg | 1 day | 10 |
| Molecular determinants of folate levels after leucovorin administration in colorectal cancer 2010 · LV 18 h group · Colorectal cancer patients scheduled to undergo surgery | 25 mg | 1 day | 10 |
| L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men 2008 · 343 microg [6S]-5-CH(3)H(4)PteGlu · healthy men | 343 mcg | 1 day | 9 |
| Folate bioavailability from breads and a meal assessed with a human stable-isotope area under the curve and ileostomy model 2010 · Whole-meal bread containing labeled 5-CH3-H4 folate · Healthy ileostomists; age and sex not reported | 200 mcg | 1 day | 8 |
| Folic acid handling by the human gut: implications for food fortification and supplementation 2014 · 13C5-6S-5-FormylTHF · Adults aged 44–61 with stable liver cirrhosis and an in situ TIPSS | 220 mcg | 1 day | 4 |
| Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid 2002 · [6S]-5-MTHF group · Women aged 18–49 years of childbearing age | 113 mcg | 24 weeks | — |
| Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease 2004 · 5 mg 5-MTHF · Patients with coronary artery disease who were homozygous for the 677C→T MTHFR mutation | 5 mg | 1 day | — |
| The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men 2004 · 500 micro g [6S]-5-MTHF capsule · Men presaturated with folic acid | 500 mcg | 1 day | — |
| [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation 2006 · [6S]-5-methylTHF group · Pregnant women enrolled at 36 weeks gestation who were healthy Canadian women during lactation | 416 mcg | 16 weeks | — |
| Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age 2006 · 416 microg [6S]-5-MTHF group · Healthy women aged 19–33 years | 416 mcg | 24 weeks | — |
| Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age 2006 · 208 microg [6S]-5-MTHF group · Healthy women aged 19–33 years | 208 mcg | 24 weeks | — |
| Unmetabolized folic acid and total folate concentrations in breast milk are unaffected by low-dose folate supplements 2009 · [6S]-5-methylTHF · Lactating women enrolled within 1 week postpartum | 416 mcg | 16 weeks | — |
| Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study 2012 · EE/drsp/levomefolate calcium · Healthy women aged 18–40 seeking contraception | 451 mcg | 24 weeks | — |
| Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone 2012 · EE/drospirenone/levomefolate calcium · Healthy women aged 18–38 years | 451 mcg | 1 day | — |
| Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone 2012 · levomefolate calcium alone · Healthy women aged 18–38 years | 451 mcg | 1 day | — |
| Wheat rolls fortified with microencapsulated L-5-methyltetrahydrofolic acid or equimolar folic acid increase blood folate concentrations to a similar extent in healthy men and women 2013 · L-5-MTHF wheat roll group · Healthy men and women aged 18–45 years | 452 mcg | 16 weeks | — |
| l-5-Methyltetrahydrofolate Supplementation Increases Blood Folate Concentrations to a Greater Extent than Folic Acid Supplementation in Malaysian Women 2018 · l-5-MTHF group · Healthy Malaysian women aged 20–45 years | 1.13 mg | 12 weeks | — |
| Supplementation with (6S)-5-methyltetrahydrofolic acid appears as effective as folic acid in maintaining maternal folate status while reducing unmetabolised folic acid in maternal plasma: a randomised trial of pregnant women in Canada 2024 · (6S)-5-MTHF group · Pregnant individuals at 8–21 weeks’ gestation | 600 mcg | 16 weeks | — |
| Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia 2013 · 5-MTHF · Adults aged 18–60 with moderate hyperhomocysteinemia | 200 mcg | 13 weeks | 39 |
| Human milk oligosaccharide composition following supplementation with folic acid vs (6S)-5-methyltetrahydrofolic acid during pregnancy and mediation by human milk folate forms 2024 · (6S)-5-MTHF group · Pregnant women recruited at 8–21 weeks’ gestation in Vancouver, Canada; no diagnosed condition stated | 625 mcg | 16 weeks | 22 |
| Folate catabolite excretion is responsive to changes in dietary folate intake in elderly women 2003 · 400 microg folate/d · Women aged 60–85 years consuming a controlled folate intake | 400 mcg | 14 weeks | 16 |
| Folate administration decreases oxidative status and blood pressure in postmenopausal women 2015 · 5-MTHF · Apparently healthy postmenopausal women | 15 mg | 3 weeks | 15 |
| Folate catabolite excretion is responsive to changes in dietary folate intake in elderly women 2003 · 200 microg folate/d · Women aged 60–85 years consuming a controlled folate intake | 200 mcg | 14 weeks | 14 |
| Effects of Maternal Fish Oil and/or 5-Methyl-Tetrahydrofolate Supplementation during Pregnancy on Offspring Brain Resting-State at 10 Years Old: A Follow-Up Study from the NUHEAL Randomized Controlled Trial 2020 · 5-MTHF · Children born to healthy pregnant women who received 5-methyl-tetrahydrofolate during pregnancy; children were assessed at 9.5–10 years | 400 mcg | — | 10 |
| Genomic DNA methylation decreases in response to moderate folate depletion in elderly women 2000 · 200 microg/d folate repletion · Healthy postmenopausal women aged 60–85 years | 200 mcg | 7 weeks | — |
| Genomic DNA methylation decreases in response to moderate folate depletion in elderly women 2000 · 415 microg/d folate repletion · Healthy postmenopausal women aged 60–85 years | 415 mcg | 7 weeks | — |
| 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women 2002 · 5-methyltetrahydrofolate · healthy young women | 480 mcg | 8 weeks | — |
| Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C-->T polymorphism of methylenetetrahydrofolate reductase 2002 · [6RS] 5-methyltetrahydrofolate · Healthy subjects, including wild-type and homozygous carriers of the MTHFR 677C-->T polymorphism | 400 mcg | 7 weeks | — |
| Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study 2003 · L-MTHF group · Healthy volunteers; age and sex not specified | 113 mcg | 24 weeks | — |
| Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women 2004 · 416 micro g [6S]-5-MTHF · healthy women | 416 mcg | 24 weeks | — |
| Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women 2004 · 208 micro g [6S]-5-MTHF · healthy women | 208 mcg | 24 weeks | — |
| Influence of Dietary Supplementation for Hyperhomocysteinemia Treatments 2020 · traditional · Adults aged 48 ± 14 years, men and women, with moderate hyperhomocysteinemia | 15 mg | 90 days | — |
| Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 1997 · folinic acid · Adults aged 26–70 with long-standing ulcerative colitis in remission for at least 1 month | 15 mg | 90 days | — |
| Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age 2024 · 800 µg group · Nonpregnant women aged 18–45 years in good physical and mental health | 400 mcg | 8 weeks | 101 |
| Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age 2024 · 400 µg group · Nonpregnant women aged 18–45 years in good physical and mental health | 200 mcg | 8 weeks | 100 |
| Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid 2002 · Folinic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia | 20 mg | 12 weeks | 22 |
| Human milk unmetabolized folic acid is increased following supplementation with synthetic folic acid as compared to (6S)-5-methyltetrahydrofolic acid 2023 · (6S)-5-MTHF · Pregnant women aged 19–42 years with singleton pregnancies, continuing supplementation through approximately 1 week postpartum | 625 mcg | 24 weeks | 22 |
| L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men 2008 · 343 microg [6S]-5-CH(3)H(4)PteGlu with 289.4 mg L-AA · healthy men | 343 mcg | 1 day | 9 |
| L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men 2008 · 343 microg [6S]-5-CH(3)H(4)PteGlu with 973.8 mg L-AA · healthy men | 343 mcg | 1 day | 9 |
| Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways(TM)) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial 2024 · methylfolate, P5P, and methylcobalamin · Adults aged 40–75 with elevated homocysteine, LDL-C of 70–190 mg/dL, and at least one minor allele in a specified MTHFR, MTR, or MTRR polymorphism | 2 mg | 180 days | 27 |
| Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients 2000 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis | 17 mg | 12 weeks | 25 |
| Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients 2001 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis | 17 mg | 12 weeks | 25 |
| Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients 2001 · L-folinic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis | 20 mg | 12 weeks | 24 |
| Effects of Maternal Fish Oil and/or 5-Methyl-Tetrahydrofolate Supplementation during Pregnancy on Offspring Brain Resting-State at 10 Years Old: A Follow-Up Study from the NUHEAL Randomized Controlled Trial 2020 · FO + 5-MTHF · Children born to healthy pregnant women who received fish oil and 5-methyl-tetrahydrofolate during pregnancy; children were assessed at 9.5–10 years | 400 mcg | — | 14 |
| Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients 2001 · Hemodialysis patients receiving MTHF · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients | 17 mg | 12 weeks | — |
| Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12 2002 · Group 2 · Chronic haemodialysis patients; age and sex not specified | 7.14 mg | 26 weeks | — |
| Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity 1994 · folate · Premature infants born at <1800 g and <36 weeks' gestation | 100 mcg | 120 days | — |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · MMS · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 400 mcg | — | 439 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · LNS · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 2.8 mg | — | 418 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · MMN · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 2.8 mg | — | 415 |
| Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers 2018 · D + Ca + B · Adults, mean age 68.4 years; no specific condition stated | 500 mcg | 1 year | 32 |
| Micronutrients in support to the one carbon cycle for the modulation of blood fasting homocysteine in PCOS women 2020 · Active treatment group · Women aged 19–35 with polycystic ovary syndrome (PCOS) | 400 mcg | 93 days | 22 |
| Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity 1994 · folate plus vitamin B-12 · Premature infants born at <1800 g and <36 weeks' gestation | 100 mcg | 120 days | — |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · Fe30F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 400 mcg | — | 458 |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · Fe60F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 400 mcg | — | 454 |